Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,818 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma.
Cognetti DM, Johnson JM, Curry JM, Kochuparambil ST, McDonald D, Mott F, Fidler MJ, Stenson K, Vasan NR, Razaq MA, Campana J, Ha P, Mann G, Ishida K, Garcia-Guzman M, Biel M, Gillenwater AM. Cognetti DM, et al. Among authors: ishida k. Head Neck. 2021 Dec;43(12):3875-3887. doi: 10.1002/hed.26885. Epub 2021 Oct 9. Head Neck. 2021. PMID: 34626024 Free PMC article. Clinical Trial.
A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma.
Tahara M, Okano S, Enokida T, Ueda Y, Fujisawa T, Shinozaki T, Tomioka T, Okano W, Biel MA, Ishida K, Hayashi R. Tahara M, et al. Among authors: ishida k. Int J Clin Oncol. 2021 Oct;26(10):1812-1821. doi: 10.1007/s10147-021-01960-6. Epub 2021 Jun 24. Int J Clin Oncol. 2021. PMID: 34165660 Free PMC article. Clinical Trial.
Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database.
Ishigaki K, Tokito Y, Takahara N, Nishio H, Endo G, Fukuda K, Ishida K, Fukuda R, Takaoka S, Oyama H, Noguchi K, Suzuki T, Sato T, Saito T, Hamada T, Miyabayashi K, Sato Y, Nakai Y, Kage H, Oda K, Fujishiro M. Ishigaki K, et al. Among authors: ishida k. J Gastroenterol. 2024 Nov 21. doi: 10.1007/s00535-024-02173-0. Online ahead of print. J Gastroenterol. 2024. PMID: 39570378
Cephalopod-inspired jetting devices for gastrointestinal drug delivery.
Arrick G, Sticker D, Ghazal A, Lu Y, Duncombe T, Gwynne D, Mouridsen B, Wainer J, Jepsen JPH, Last TS, Schultz D, Hess K, Medina De Alba E, Min S, Poulsen M, Anker C, Karandikar P, Pedersen HD, Collins J, Egecioglu NE, Tamang S, Cleveland C, Ishida K, Uhrenfeldt AH, Kuosmanen J, Pereverzina M, Hayward A, Kirk RK, You S, Dalsgaard CM, Gunnarsson SB, Patsi I, Bohr A, Azzarello A, Frederiksen MR, Herskind P, Li J, Roxhed N, Rahbek UL, Water JJ, Buckley ST, Traverso G. Arrick G, et al. Among authors: ishida k. Nature. 2024 Nov 20. doi: 10.1038/s41586-024-08202-5. Online ahead of print. Nature. 2024. PMID: 39567682
Local treatment of HVJ-E with T cell costimulatory molecule stimulation elicits systemic anti-tumor effects.
Ishibashi A, Li Y, Hisatomi Y, Ohta N, Uegaki Y, Tanemura A, Ohashi R, Kitamura K, Saga K, Yoshimura Y, Inubushi S, Ishida K, Iwabuchi S, Hashimoto S, Kiyohara E, Yagita H, Kaneda Y, Nimura K. Ishibashi A, et al. Among authors: ishida k. Mol Ther Oncol. 2024 Oct 10;32(4):200893. doi: 10.1016/j.omton.2024.200893. eCollection 2024 Dec 19. Mol Ther Oncol. 2024. PMID: 39534532 Free PMC article.
Phages ZC01 and ZC03 require type-IV pilus for Pseudomonas aeruginosa infection and have a potential for therapeutic applications.
Martins LF, Dos Santos Junior AP, Nicastro GG, Scheunemann G, Angeli CB, Rossi FPN, Quaggio RB, Palmisano G, Sgro GG, Ishida K, Baldini RL, da Silva AM. Martins LF, et al. Among authors: ishida k. Microbiol Spectr. 2024 Oct 29:e0152724. doi: 10.1128/spectrum.01527-24. Online ahead of print. Microbiol Spectr. 2024. PMID: 39470273 Free article.
2,818 results